Context Therapeutics Inc.
CNTX
$0.71
-$0.02-2.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.63M | -26.73M | -30.15M | -18.57M | -21.32M |
| Total Depreciation and Amortization | 12.40K | 10.90K | 10.60K | 10.90K | 11.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.71M | 15.63M | 15.63M | 915.60K | 1.06M |
| Change in Net Operating Assets | -3.32M | -3.48M | -2.37M | -764.00K | 568.40K |
| Cash from Operations | -15.22M | -14.56M | -16.88M | -18.40M | -19.68M |
| Capital Expenditure | -41.20K | -7.30K | -7.30K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.75M | -14.75M | -14.75M | -- | -- |
| Cash from Investing | -14.79M | -14.76M | -14.76M | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 109.34M | 109.34M | 94.80M | 94.80M | -- |
| Repurchase of Common Stock | -44.60K | -44.60K | -44.60K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -15.30K | -- | -- | -- | -- |
| Cash from Financing | 109.28M | 109.29M | 94.76M | 94.80M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.26M | 79.98M | 63.12M | 76.40M | -19.68M |